Subtherapeutic Linezolid Concentration in a Patient With Bullous Pemphigoid Complicated by Methicillin-Resistant Staphylococcus aureus Infection: A Case Study
- PMID: 32217880
- DOI: 10.1097/FTD.0000000000000758
Subtherapeutic Linezolid Concentration in a Patient With Bullous Pemphigoid Complicated by Methicillin-Resistant Staphylococcus aureus Infection: A Case Study
Abstract
We presented a case of subtherapeutic linezolid concentration in a patient with bullous pemphigoid characterized by large area skin anabrosis complicated by methicillin-resistant Staphylococcus aureus infections.
References
-
- Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines y the infectious diseases society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. Clin Infect Dis. 2011;52:285–292.
-
- Stevens DL, Bisno AL, Chambers HF, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clin Infect Dis. 2014;59:e10–52.
-
- Blassmann U, Roehr AC, Frey OR, et al. Decreased linezolid serum concentrations in three critically ill patients: clinical case studies of a potential drug interaction between linezolid and rifampicin. Pharmacology 2016;98:51–55.
-
- Zoller M, Maier B, Hornuss C, et al. Variability of linezolid concentrations after standard dosing in critically ill patients: a prospective observational study. Crit Care 2014;18:R148.
-
- Cojutti P, Crapis M, Bassetti M, et al. Linezolid underexposure in a patient co-treated with venlafaxine. Eur J Clin Pharmacol. 2015;71:1285–1286.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
